nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—Cyclophosphamide—Mechlorethamine—hematologic cancer	0.239	1	CrCrCtD
Ifosfamide—Alkylating Activity—Busulfan—hematologic cancer	0.0843	0.167	CiPCiCtD
Ifosfamide—Alkylating Activity—Lomustine—hematologic cancer	0.0639	0.127	CiPCiCtD
Ifosfamide—Alkylating Activity—Procarbazine—hematologic cancer	0.0639	0.127	CiPCiCtD
Ifosfamide—Alkylating Activity—Mechlorethamine—hematologic cancer	0.0639	0.127	CiPCiCtD
Ifosfamide—Alkylating Activity—Thiotepa—hematologic cancer	0.0484	0.0961	CiPCiCtD
Ifosfamide—Alkylating Activity—Chlorambucil—hematologic cancer	0.0484	0.0961	CiPCiCtD
Ifosfamide—Alkylating Activity—Melphalan—hematologic cancer	0.0484	0.0961	CiPCiCtD
Ifosfamide—Alkylating Activity—Carmustine—hematologic cancer	0.0443	0.0879	CiPCiCtD
Ifosfamide—Alkylating Activity—Dacarbazine—hematologic cancer	0.0387	0.0768	CiPCiCtD
Ifosfamide—CYP2A6—Methoxsalen—hematologic cancer	0.00801	0.0492	CbGbCtD
Ifosfamide—CYP2B6—Thiotepa—hematologic cancer	0.00671	0.0412	CbGbCtD
Ifosfamide—PTGS1—Bortezomib—hematologic cancer	0.00651	0.04	CbGbCtD
Ifosfamide—PTGS1—Thalidomide—hematologic cancer	0.00567	0.0348	CbGbCtD
Ifosfamide—PTGS1—Imatinib—hematologic cancer	0.00477	0.0293	CbGbCtD
Ifosfamide—CYP2C9—Bexarotene—hematologic cancer	0.00428	0.0263	CbGbCtD
Ifosfamide—CYP2A6—Prednisolone—hematologic cancer	0.0039	0.0239	CbGbCtD
Ifosfamide—CYP3A7—Imatinib—hematologic cancer	0.00382	0.0234	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.00382	0.0234	CbGbCtD
Ifosfamide—CYP2C8—Bortezomib—hematologic cancer	0.00376	0.0231	CbGbCtD
Ifosfamide—CYP3A5—Daunorubicin—hematologic cancer	0.00374	0.023	CbGbCtD
Ifosfamide—CYP2C9—Idarubicin—hematologic cancer	0.00354	0.0218	CbGbCtD
Ifosfamide—CYP3A5—Thalidomide—hematologic cancer	0.0034	0.0209	CbGbCtD
Ifosfamide—CYP2B6—Nilotinib—hematologic cancer	0.0033	0.0203	CbGbCtD
Ifosfamide—CYP3A5—Teniposide—hematologic cancer	0.00325	0.0199	CbGbCtD
Ifosfamide—CYP2C19—Bortezomib—hematologic cancer	0.00315	0.0194	CbGbCtD
Ifosfamide—CYP3A5—Imatinib—hematologic cancer	0.00286	0.0176	CbGbCtD
Ifosfamide—CYP2C19—Thalidomide—hematologic cancer	0.00275	0.0169	CbGbCtD
Ifosfamide—CYP2C9—Bortezomib—hematologic cancer	0.00262	0.0161	CbGbCtD
Ifosfamide—CYP2C19—Teniposide—hematologic cancer	0.00262	0.0161	CbGbCtD
Ifosfamide—CYP2C8—Nilotinib—hematologic cancer	0.0025	0.0154	CbGbCtD
Ifosfamide—CYP3A4—Bexarotene—hematologic cancer	0.00249	0.0153	CbGbCtD
Ifosfamide—PTGS1—Etoposide—hematologic cancer	0.00239	0.0147	CbGbCtD
Ifosfamide—CYP3A7—Irinotecan—hematologic cancer	0.00238	0.0146	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00238	0.0146	CbGbCtD
Ifosfamide—CYP3A4—Busulfan—hematologic cancer	0.00231	0.0142	CbGbCtD
Ifosfamide—CYP3A4—Lomustine—hematologic cancer	0.00231	0.0142	CbGbCtD
Ifosfamide—CYP2C19—Imatinib—hematologic cancer	0.00231	0.0142	CbGbCtD
Ifosfamide—CYP3A5—Dasatinib—hematologic cancer	0.0023	0.0141	CbGbCtD
Ifosfamide—CYP2A6—Dexamethasone—hematologic cancer	0.0023	0.0141	CbGbCtD
Ifosfamide—CYP2C9—Thalidomide—hematologic cancer	0.00228	0.014	CbGbCtD
Ifosfamide—CYP2B6—Irinotecan—hematologic cancer	0.00227	0.0139	CbGbCtD
Ifosfamide—CYP2C9—Teniposide—hematologic cancer	0.00218	0.0134	CbGbCtD
Ifosfamide—CYP3A7—Vincristine—hematologic cancer	0.00208	0.0128	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00208	0.0128	CbGbCtD
Ifosfamide—CYP3A4—Thiotepa—hematologic cancer	0.00206	0.0127	CbGbCtD
Ifosfamide—CYP2C9—Imatinib—hematologic cancer	0.00192	0.0118	CbGbCtD
Ifosfamide—CYP2B6—Cisplatin—hematologic cancer	0.00185	0.0114	CbGbCtD
Ifosfamide—CYP3A5—Irinotecan—hematologic cancer	0.00179	0.011	CbGbCtD
Ifosfamide—CYP2C9—Nilotinib—hematologic cancer	0.00174	0.0107	CbGbCtD
Ifosfamide—CYP3A4—Methoxsalen—hematologic cancer	0.0016	0.00984	CbGbCtD
Ifosfamide—CYP3A7—Dexamethasone—hematologic cancer	0.00157	0.00964	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00157	0.00964	CbGbCtD
Ifosfamide—CYP3A5—Vincristine—hematologic cancer	0.00156	0.0096	CbGbCtD
Ifosfamide—CYP3A4—Bortezomib—hematologic cancer	0.00152	0.00936	CbGbCtD
Ifosfamide—CYP2C19—Prednisone—hematologic cancer	0.00152	0.00934	CbGbCtD
Ifosfamide—CYP2B6—Dexamethasone—hematologic cancer	0.0015	0.00918	CbGbCtD
Ifosfamide—CYP3A4—Daunorubicin—hematologic cancer	0.00146	0.00895	CbGbCtD
Ifosfamide—CYP3A5—Etoposide—hematologic cancer	0.00143	0.0088	CbGbCtD
Ifosfamide—CYP2C8—Etoposide—hematologic cancer	0.00138	0.00846	CbGbCtD
Ifosfamide—CYP3A4—Cytarabine—hematologic cancer	0.00129	0.0079	CbGbCtD
Ifosfamide—CYP3A4—Teniposide—hematologic cancer	0.00127	0.00778	CbGbCtD
Ifosfamide—CYP2B6—Doxorubicin—hematologic cancer	0.00124	0.00762	CbGbCtD
Ifosfamide—CYP3A5—Dexamethasone—hematologic cancer	0.00118	0.00723	CbGbCtD
Ifosfamide—CYP2C8—Dexamethasone—hematologic cancer	0.00113	0.00695	CbGbCtD
Ifosfamide—CYP3A4—Imatinib—hematologic cancer	0.00112	0.00686	CbGbCtD
Ifosfamide—CYP3A4—Ruxolitinib—hematologic cancer	0.00105	0.00646	CbGbCtD
Ifosfamide—CYP3A4—Nilotinib—hematologic cancer	0.00101	0.00623	CbGbCtD
Ifosfamide—CYP3A4—Vinorelbine—hematologic cancer	0.00101	0.00618	CbGbCtD
Ifosfamide—CYP2C9—Cisplatin—hematologic cancer	0.000978	0.006	CbGbCtD
Ifosfamide—CYP2C19—Dexamethasone—hematologic cancer	0.00095	0.00583	CbGbCtD
Ifosfamide—CYP3A4—Triamcinolone—hematologic cancer	0.00092	0.00565	CbGbCtD
Ifosfamide—CYP3A4—Dasatinib—hematologic cancer	0.000897	0.00551	CbGbCtD
Ifosfamide—CYP3A4—Mitoxantrone—hematologic cancer	0.000886	0.00544	CbGbCtD
Ifosfamide—CYP2C9—Dexamethasone—hematologic cancer	0.00079	0.00485	CbGbCtD
Ifosfamide—CYP3A4—Betamethasone—hematologic cancer	0.000789	0.00485	CbGbCtD
Ifosfamide—CYP3A4—Prednisolone—hematologic cancer	0.000779	0.00478	CbGbCtD
Ifosfamide—CYP3A4—Prednisone—hematologic cancer	0.000736	0.00452	CbGbCtD
Ifosfamide—CYP3A4—Irinotecan—hematologic cancer	0.000697	0.00428	CbGbCtD
Ifosfamide—CYP3A4—Vinblastine—hematologic cancer	0.00062	0.00381	CbGbCtD
Ifosfamide—CYP3A4—Vincristine—hematologic cancer	0.00061	0.00374	CbGbCtD
Ifosfamide—CYP3A4—Etoposide—hematologic cancer	0.000559	0.00343	CbGbCtD
Ifosfamide—CYP3A4—Dexamethasone—hematologic cancer	0.000459	0.00282	CbGbCtD
Ifosfamide—CYP3A4—Doxorubicin—hematologic cancer	0.000381	0.00234	CbGbCtD
Ifosfamide—Cyclophosphamide—ABCB1—hematologic cancer	9.03e-06	1	CrCbGaD
Ifosfamide—Urethral disorder—Doxorubicin—hematologic cancer	3.54e-06	4.08e-05	CcSEcCtD
Ifosfamide—Decreased appetite—Dexamethasone—hematologic cancer	3.54e-06	4.08e-05	CcSEcCtD
Ifosfamide—Decreased appetite—Betamethasone—hematologic cancer	3.54e-06	4.08e-05	CcSEcCtD
Ifosfamide—Nausea—Irinotecan—hematologic cancer	3.53e-06	4.07e-05	CcSEcCtD
Ifosfamide—Nausea—Mitoxantrone—hematologic cancer	3.53e-06	4.07e-05	CcSEcCtD
Ifosfamide—Immune system disorder—Epirubicin—hematologic cancer	3.53e-06	4.06e-05	CcSEcCtD
Ifosfamide—Infection—Prednisone—hematologic cancer	3.52e-06	4.06e-05	CcSEcCtD
Ifosfamide—Mediastinal disorder—Epirubicin—hematologic cancer	3.52e-06	4.05e-05	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.52e-06	4.05e-05	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.52e-06	4.05e-05	CcSEcCtD
Ifosfamide—Fatigue—Dexamethasone—hematologic cancer	3.51e-06	4.05e-05	CcSEcCtD
Ifosfamide—Fatigue—Betamethasone—hematologic cancer	3.51e-06	4.05e-05	CcSEcCtD
Ifosfamide—Chills—Epirubicin—hematologic cancer	3.5e-06	4.04e-05	CcSEcCtD
Ifosfamide—Pruritus—Etoposide—hematologic cancer	3.5e-06	4.03e-05	CcSEcCtD
Ifosfamide—Arrhythmia—Epirubicin—hematologic cancer	3.49e-06	4.02e-05	CcSEcCtD
Ifosfamide—Pain—Dexamethasone—hematologic cancer	3.48e-06	4.01e-05	CcSEcCtD
Ifosfamide—Pain—Betamethasone—hematologic cancer	3.48e-06	4.01e-05	CcSEcCtD
Ifosfamide—Visual impairment—Doxorubicin—hematologic cancer	3.48e-06	4.01e-05	CcSEcCtD
Ifosfamide—Nervous system disorder—Prednisone—hematologic cancer	3.48e-06	4.01e-05	CcSEcCtD
Ifosfamide—Alopecia—Epirubicin—hematologic cancer	3.45e-06	3.97e-05	CcSEcCtD
Ifosfamide—Skin disorder—Prednisone—hematologic cancer	3.44e-06	3.97e-05	CcSEcCtD
Ifosfamide—Nausea—Gemcitabine—hematologic cancer	3.44e-06	3.97e-05	CcSEcCtD
Ifosfamide—Vomiting—Cisplatin—hematologic cancer	3.43e-06	3.96e-05	CcSEcCtD
Ifosfamide—Hyperhidrosis—Prednisone—hematologic cancer	3.43e-06	3.95e-05	CcSEcCtD
Ifosfamide—Vision blurred—Methotrexate—hematologic cancer	3.42e-06	3.94e-05	CcSEcCtD
Ifosfamide—Mental disorder—Epirubicin—hematologic cancer	3.42e-06	3.94e-05	CcSEcCtD
Ifosfamide—Erythema multiforme—Doxorubicin—hematologic cancer	3.42e-06	3.94e-05	CcSEcCtD
Ifosfamide—Rash—Cisplatin—hematologic cancer	3.41e-06	3.92e-05	CcSEcCtD
Ifosfamide—Dermatitis—Cisplatin—hematologic cancer	3.4e-06	3.92e-05	CcSEcCtD
Ifosfamide—Malnutrition—Epirubicin—hematologic cancer	3.4e-06	3.92e-05	CcSEcCtD
Ifosfamide—Erythema—Epirubicin—hematologic cancer	3.4e-06	3.92e-05	CcSEcCtD
Ifosfamide—Diarrhoea—Etoposide—hematologic cancer	3.39e-06	3.9e-05	CcSEcCtD
Ifosfamide—Anorexia—Prednisone—hematologic cancer	3.38e-06	3.89e-05	CcSEcCtD
Ifosfamide—Eye disorder—Doxorubicin—hematologic cancer	3.38e-06	3.89e-05	CcSEcCtD
Ifosfamide—Ill-defined disorder—Methotrexate—hematologic cancer	3.37e-06	3.88e-05	CcSEcCtD
Ifosfamide—Tinnitus—Doxorubicin—hematologic cancer	3.37e-06	3.88e-05	CcSEcCtD
Ifosfamide—Anaemia—Methotrexate—hematologic cancer	3.36e-06	3.87e-05	CcSEcCtD
Ifosfamide—Feeling abnormal—Dexamethasone—hematologic cancer	3.36e-06	3.87e-05	CcSEcCtD
Ifosfamide—Feeling abnormal—Betamethasone—hematologic cancer	3.36e-06	3.87e-05	CcSEcCtD
Ifosfamide—Flushing—Doxorubicin—hematologic cancer	3.35e-06	3.86e-05	CcSEcCtD
Ifosfamide—Cardiac disorder—Doxorubicin—hematologic cancer	3.35e-06	3.86e-05	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Betamethasone—hematologic cancer	3.33e-06	3.84e-05	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.33e-06	3.84e-05	CcSEcCtD
Ifosfamide—Hypersensitivity—Triamcinolone—hematologic cancer	3.31e-06	3.81e-05	CcSEcCtD
Ifosfamide—Angiopathy—Doxorubicin—hematologic cancer	3.28e-06	3.78e-05	CcSEcCtD
Ifosfamide—Malaise—Methotrexate—hematologic cancer	3.27e-06	3.77e-05	CcSEcCtD
Ifosfamide—Dizziness—Etoposide—hematologic cancer	3.27e-06	3.77e-05	CcSEcCtD
Ifosfamide—Immune system disorder—Doxorubicin—hematologic cancer	3.26e-06	3.76e-05	CcSEcCtD
Ifosfamide—Vertigo—Methotrexate—hematologic cancer	3.26e-06	3.76e-05	CcSEcCtD
Ifosfamide—Mediastinal disorder—Doxorubicin—hematologic cancer	3.26e-06	3.75e-05	CcSEcCtD
Ifosfamide—Leukopenia—Methotrexate—hematologic cancer	3.25e-06	3.75e-05	CcSEcCtD
Ifosfamide—Chills—Doxorubicin—hematologic cancer	3.24e-06	3.73e-05	CcSEcCtD
Ifosfamide—Urticaria—Betamethasone—hematologic cancer	3.24e-06	3.73e-05	CcSEcCtD
Ifosfamide—Urticaria—Dexamethasone—hematologic cancer	3.24e-06	3.73e-05	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.23e-06	3.72e-05	CcSEcCtD
Ifosfamide—Dizziness—Prednisolone—hematologic cancer	3.23e-06	3.72e-05	CcSEcCtD
Ifosfamide—Arrhythmia—Doxorubicin—hematologic cancer	3.23e-06	3.72e-05	CcSEcCtD
Ifosfamide—Asthenia—Triamcinolone—hematologic cancer	3.22e-06	3.71e-05	CcSEcCtD
Ifosfamide—Body temperature increased—Dexamethasone—hematologic cancer	3.22e-06	3.71e-05	CcSEcCtD
Ifosfamide—Abdominal pain—Dexamethasone—hematologic cancer	3.22e-06	3.71e-05	CcSEcCtD
Ifosfamide—Abdominal pain—Betamethasone—hematologic cancer	3.22e-06	3.71e-05	CcSEcCtD
Ifosfamide—Body temperature increased—Betamethasone—hematologic cancer	3.22e-06	3.71e-05	CcSEcCtD
Ifosfamide—Nausea—Cisplatin—hematologic cancer	3.21e-06	3.7e-05	CcSEcCtD
Ifosfamide—Vision blurred—Epirubicin—hematologic cancer	3.2e-06	3.69e-05	CcSEcCtD
Ifosfamide—Alopecia—Doxorubicin—hematologic cancer	3.19e-06	3.68e-05	CcSEcCtD
Ifosfamide—Paraesthesia—Prednisone—hematologic cancer	3.18e-06	3.67e-05	CcSEcCtD
Ifosfamide—Pruritus—Triamcinolone—hematologic cancer	3.18e-06	3.66e-05	CcSEcCtD
Ifosfamide—Cough—Methotrexate—hematologic cancer	3.17e-06	3.65e-05	CcSEcCtD
Ifosfamide—Mental disorder—Doxorubicin—hematologic cancer	3.16e-06	3.65e-05	CcSEcCtD
Ifosfamide—Ill-defined disorder—Epirubicin—hematologic cancer	3.15e-06	3.63e-05	CcSEcCtD
Ifosfamide—Convulsion—Methotrexate—hematologic cancer	3.15e-06	3.63e-05	CcSEcCtD
Ifosfamide—Vomiting—Etoposide—hematologic cancer	3.15e-06	3.62e-05	CcSEcCtD
Ifosfamide—Erythema—Doxorubicin—hematologic cancer	3.14e-06	3.62e-05	CcSEcCtD
Ifosfamide—Malnutrition—Doxorubicin—hematologic cancer	3.14e-06	3.62e-05	CcSEcCtD
Ifosfamide—Anaemia—Epirubicin—hematologic cancer	3.14e-06	3.62e-05	CcSEcCtD
Ifosfamide—Agitation—Epirubicin—hematologic cancer	3.12e-06	3.6e-05	CcSEcCtD
Ifosfamide—Rash—Etoposide—hematologic cancer	3.12e-06	3.59e-05	CcSEcCtD
Ifosfamide—Dermatitis—Etoposide—hematologic cancer	3.12e-06	3.59e-05	CcSEcCtD
Ifosfamide—Chest pain—Methotrexate—hematologic cancer	3.09e-06	3.56e-05	CcSEcCtD
Ifosfamide—Arthralgia—Methotrexate—hematologic cancer	3.09e-06	3.56e-05	CcSEcCtD
Ifosfamide—Myalgia—Methotrexate—hematologic cancer	3.09e-06	3.56e-05	CcSEcCtD
Ifosfamide—Decreased appetite—Prednisone—hematologic cancer	3.08e-06	3.55e-05	CcSEcCtD
Ifosfamide—Rash—Prednisolone—hematologic cancer	3.08e-06	3.55e-05	CcSEcCtD
Ifosfamide—Dermatitis—Prednisolone—hematologic cancer	3.07e-06	3.54e-05	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.07e-06	3.54e-05	CcSEcCtD
Ifosfamide—Malaise—Epirubicin—hematologic cancer	3.06e-06	3.53e-05	CcSEcCtD
Ifosfamide—Fatigue—Prednisone—hematologic cancer	3.06e-06	3.52e-05	CcSEcCtD
Ifosfamide—Discomfort—Methotrexate—hematologic cancer	3.05e-06	3.52e-05	CcSEcCtD
Ifosfamide—Vertigo—Epirubicin—hematologic cancer	3.05e-06	3.52e-05	CcSEcCtD
Ifosfamide—Leukopenia—Epirubicin—hematologic cancer	3.04e-06	3.5e-05	CcSEcCtD
Ifosfamide—Constipation—Prednisone—hematologic cancer	3.03e-06	3.49e-05	CcSEcCtD
Ifosfamide—Palpitations—Epirubicin—hematologic cancer	3e-06	3.46e-05	CcSEcCtD
Ifosfamide—Confusional state—Methotrexate—hematologic cancer	2.99e-06	3.44e-05	CcSEcCtD
Ifosfamide—Dizziness—Triamcinolone—hematologic cancer	2.97e-06	3.42e-05	CcSEcCtD
Ifosfamide—Cough—Epirubicin—hematologic cancer	2.97e-06	3.42e-05	CcSEcCtD
Ifosfamide—Anaphylactic shock—Methotrexate—hematologic cancer	2.96e-06	3.41e-05	CcSEcCtD
Ifosfamide—Vision blurred—Doxorubicin—hematologic cancer	2.96e-06	3.41e-05	CcSEcCtD
Ifosfamide—Convulsion—Epirubicin—hematologic cancer	2.94e-06	3.39e-05	CcSEcCtD
Ifosfamide—Infection—Methotrexate—hematologic cancer	2.94e-06	3.39e-05	CcSEcCtD
Ifosfamide—Nausea—Etoposide—hematologic cancer	2.94e-06	3.39e-05	CcSEcCtD
Ifosfamide—Hypertension—Epirubicin—hematologic cancer	2.93e-06	3.38e-05	CcSEcCtD
Ifosfamide—Feeling abnormal—Prednisone—hematologic cancer	2.92e-06	3.37e-05	CcSEcCtD
Ifosfamide—Asthenia—Betamethasone—hematologic cancer	2.92e-06	3.37e-05	CcSEcCtD
Ifosfamide—Asthenia—Dexamethasone—hematologic cancer	2.92e-06	3.37e-05	CcSEcCtD
Ifosfamide—Ill-defined disorder—Doxorubicin—hematologic cancer	2.92e-06	3.36e-05	CcSEcCtD
Ifosfamide—Nervous system disorder—Methotrexate—hematologic cancer	2.91e-06	3.35e-05	CcSEcCtD
Ifosfamide—Anaemia—Doxorubicin—hematologic cancer	2.91e-06	3.35e-05	CcSEcCtD
Ifosfamide—Thrombocytopenia—Methotrexate—hematologic cancer	2.9e-06	3.34e-05	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Prednisone—hematologic cancer	2.9e-06	3.34e-05	CcSEcCtD
Ifosfamide—Nausea—Prednisolone—hematologic cancer	2.9e-06	3.34e-05	CcSEcCtD
Ifosfamide—Chest pain—Epirubicin—hematologic cancer	2.89e-06	3.33e-05	CcSEcCtD
Ifosfamide—Arthralgia—Epirubicin—hematologic cancer	2.89e-06	3.33e-05	CcSEcCtD
Ifosfamide—Myalgia—Epirubicin—hematologic cancer	2.89e-06	3.33e-05	CcSEcCtD
Ifosfamide—Agitation—Doxorubicin—hematologic cancer	2.89e-06	3.33e-05	CcSEcCtD
Ifosfamide—Pruritus—Dexamethasone—hematologic cancer	2.88e-06	3.32e-05	CcSEcCtD
Ifosfamide—Pruritus—Betamethasone—hematologic cancer	2.88e-06	3.32e-05	CcSEcCtD
Ifosfamide—Skin disorder—Methotrexate—hematologic cancer	2.88e-06	3.32e-05	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.87e-06	3.31e-05	CcSEcCtD
Ifosfamide—Hyperhidrosis—Methotrexate—hematologic cancer	2.87e-06	3.3e-05	CcSEcCtD
Ifosfamide—Discomfort—Epirubicin—hematologic cancer	2.86e-06	3.29e-05	CcSEcCtD
Ifosfamide—Vomiting—Triamcinolone—hematologic cancer	2.85e-06	3.29e-05	CcSEcCtD
Ifosfamide—Malaise—Doxorubicin—hematologic cancer	2.84e-06	3.27e-05	CcSEcCtD
Ifosfamide—Rash—Triamcinolone—hematologic cancer	2.83e-06	3.26e-05	CcSEcCtD
Ifosfamide—Dermatitis—Triamcinolone—hematologic cancer	2.83e-06	3.26e-05	CcSEcCtD
Ifosfamide—Vertigo—Doxorubicin—hematologic cancer	2.83e-06	3.26e-05	CcSEcCtD
Ifosfamide—Anorexia—Methotrexate—hematologic cancer	2.83e-06	3.26e-05	CcSEcCtD
Ifosfamide—Urticaria—Prednisone—hematologic cancer	2.82e-06	3.25e-05	CcSEcCtD
Ifosfamide—Leukopenia—Doxorubicin—hematologic cancer	2.81e-06	3.24e-05	CcSEcCtD
Ifosfamide—Abdominal pain—Prednisone—hematologic cancer	2.8e-06	3.23e-05	CcSEcCtD
Ifosfamide—Body temperature increased—Prednisone—hematologic cancer	2.8e-06	3.23e-05	CcSEcCtD
Ifosfamide—Confusional state—Epirubicin—hematologic cancer	2.8e-06	3.22e-05	CcSEcCtD
Ifosfamide—Diarrhoea—Betamethasone—hematologic cancer	2.79e-06	3.21e-05	CcSEcCtD
Ifosfamide—Diarrhoea—Dexamethasone—hematologic cancer	2.79e-06	3.21e-05	CcSEcCtD
Ifosfamide—Palpitations—Doxorubicin—hematologic cancer	2.78e-06	3.2e-05	CcSEcCtD
Ifosfamide—Anaphylactic shock—Epirubicin—hematologic cancer	2.77e-06	3.2e-05	CcSEcCtD
Ifosfamide—Oedema—Epirubicin—hematologic cancer	2.77e-06	3.2e-05	CcSEcCtD
Ifosfamide—Hypotension—Methotrexate—hematologic cancer	2.77e-06	3.19e-05	CcSEcCtD
Ifosfamide—Infection—Epirubicin—hematologic cancer	2.76e-06	3.17e-05	CcSEcCtD
Ifosfamide—Cough—Doxorubicin—hematologic cancer	2.74e-06	3.16e-05	CcSEcCtD
Ifosfamide—Convulsion—Doxorubicin—hematologic cancer	2.72e-06	3.14e-05	CcSEcCtD
Ifosfamide—Nervous system disorder—Epirubicin—hematologic cancer	2.72e-06	3.13e-05	CcSEcCtD
Ifosfamide—Thrombocytopenia—Epirubicin—hematologic cancer	2.72e-06	3.13e-05	CcSEcCtD
Ifosfamide—Hypertension—Doxorubicin—hematologic cancer	2.71e-06	3.13e-05	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.7e-06	3.11e-05	CcSEcCtD
Ifosfamide—Skin disorder—Epirubicin—hematologic cancer	2.69e-06	3.1e-05	CcSEcCtD
Ifosfamide—Dizziness—Betamethasone—hematologic cancer	2.69e-06	3.1e-05	CcSEcCtD
Ifosfamide—Dizziness—Dexamethasone—hematologic cancer	2.69e-06	3.1e-05	CcSEcCtD
Ifosfamide—Hyperhidrosis—Epirubicin—hematologic cancer	2.68e-06	3.09e-05	CcSEcCtD
Ifosfamide—Chest pain—Doxorubicin—hematologic cancer	2.68e-06	3.08e-05	CcSEcCtD
Ifosfamide—Arthralgia—Doxorubicin—hematologic cancer	2.68e-06	3.08e-05	CcSEcCtD
Ifosfamide—Myalgia—Doxorubicin—hematologic cancer	2.68e-06	3.08e-05	CcSEcCtD
Ifosfamide—Nausea—Triamcinolone—hematologic cancer	2.67e-06	3.07e-05	CcSEcCtD
Ifosfamide—Paraesthesia—Methotrexate—hematologic cancer	2.66e-06	3.07e-05	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.66e-06	3.06e-05	CcSEcCtD
Ifosfamide—Discomfort—Doxorubicin—hematologic cancer	2.65e-06	3.05e-05	CcSEcCtD
Ifosfamide—Anorexia—Epirubicin—hematologic cancer	2.64e-06	3.05e-05	CcSEcCtD
Ifosfamide—Dyspnoea—Methotrexate—hematologic cancer	2.64e-06	3.04e-05	CcSEcCtD
Ifosfamide—Somnolence—Methotrexate—hematologic cancer	2.63e-06	3.04e-05	CcSEcCtD
Ifosfamide—Hypersensitivity—Prednisone—hematologic cancer	2.61e-06	3.01e-05	CcSEcCtD
Ifosfamide—Hypotension—Epirubicin—hematologic cancer	2.59e-06	2.99e-05	CcSEcCtD
Ifosfamide—Vomiting—Betamethasone—hematologic cancer	2.59e-06	2.98e-05	CcSEcCtD
Ifosfamide—Vomiting—Dexamethasone—hematologic cancer	2.59e-06	2.98e-05	CcSEcCtD
Ifosfamide—Confusional state—Doxorubicin—hematologic cancer	2.59e-06	2.98e-05	CcSEcCtD
Ifosfamide—Decreased appetite—Methotrexate—hematologic cancer	2.58e-06	2.97e-05	CcSEcCtD
Ifosfamide—Rash—Betamethasone—hematologic cancer	2.57e-06	2.96e-05	CcSEcCtD
Ifosfamide—Rash—Dexamethasone—hematologic cancer	2.57e-06	2.96e-05	CcSEcCtD
Ifosfamide—Anaphylactic shock—Doxorubicin—hematologic cancer	2.57e-06	2.96e-05	CcSEcCtD
Ifosfamide—Oedema—Doxorubicin—hematologic cancer	2.57e-06	2.96e-05	CcSEcCtD
Ifosfamide—Dermatitis—Betamethasone—hematologic cancer	2.57e-06	2.96e-05	CcSEcCtD
Ifosfamide—Dermatitis—Dexamethasone—hematologic cancer	2.57e-06	2.96e-05	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.56e-06	2.95e-05	CcSEcCtD
Ifosfamide—Fatigue—Methotrexate—hematologic cancer	2.56e-06	2.94e-05	CcSEcCtD
Ifosfamide—Infection—Doxorubicin—hematologic cancer	2.55e-06	2.94e-05	CcSEcCtD
Ifosfamide—Asthenia—Prednisone—hematologic cancer	2.54e-06	2.93e-05	CcSEcCtD
Ifosfamide—Pain—Methotrexate—hematologic cancer	2.53e-06	2.92e-05	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.53e-06	2.91e-05	CcSEcCtD
Ifosfamide—Nervous system disorder—Doxorubicin—hematologic cancer	2.52e-06	2.9e-05	CcSEcCtD
Ifosfamide—Thrombocytopenia—Doxorubicin—hematologic cancer	2.51e-06	2.9e-05	CcSEcCtD
Ifosfamide—Pruritus—Prednisone—hematologic cancer	2.51e-06	2.89e-05	CcSEcCtD
Ifosfamide—Skin disorder—Doxorubicin—hematologic cancer	2.49e-06	2.87e-05	CcSEcCtD
Ifosfamide—Paraesthesia—Epirubicin—hematologic cancer	2.49e-06	2.87e-05	CcSEcCtD
Ifosfamide—Hyperhidrosis—Doxorubicin—hematologic cancer	2.48e-06	2.86e-05	CcSEcCtD
Ifosfamide—Dyspnoea—Epirubicin—hematologic cancer	2.47e-06	2.85e-05	CcSEcCtD
Ifosfamide—Somnolence—Epirubicin—hematologic cancer	2.47e-06	2.84e-05	CcSEcCtD
Ifosfamide—Anorexia—Doxorubicin—hematologic cancer	2.45e-06	2.82e-05	CcSEcCtD
Ifosfamide—Feeling abnormal—Methotrexate—hematologic cancer	2.44e-06	2.81e-05	CcSEcCtD
Ifosfamide—Diarrhoea—Prednisone—hematologic cancer	2.43e-06	2.8e-05	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Methotrexate—hematologic cancer	2.42e-06	2.79e-05	CcSEcCtD
Ifosfamide—Nausea—Dexamethasone—hematologic cancer	2.42e-06	2.79e-05	CcSEcCtD
Ifosfamide—Nausea—Betamethasone—hematologic cancer	2.42e-06	2.79e-05	CcSEcCtD
Ifosfamide—Decreased appetite—Epirubicin—hematologic cancer	2.41e-06	2.78e-05	CcSEcCtD
Ifosfamide—Hypotension—Doxorubicin—hematologic cancer	2.4e-06	2.76e-05	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.39e-06	2.76e-05	CcSEcCtD
Ifosfamide—Fatigue—Epirubicin—hematologic cancer	2.39e-06	2.76e-05	CcSEcCtD
Ifosfamide—Constipation—Epirubicin—hematologic cancer	2.37e-06	2.73e-05	CcSEcCtD
Ifosfamide—Pain—Epirubicin—hematologic cancer	2.37e-06	2.73e-05	CcSEcCtD
Ifosfamide—Urticaria—Methotrexate—hematologic cancer	2.35e-06	2.71e-05	CcSEcCtD
Ifosfamide—Dizziness—Prednisone—hematologic cancer	2.35e-06	2.7e-05	CcSEcCtD
Ifosfamide—Abdominal pain—Methotrexate—hematologic cancer	2.34e-06	2.7e-05	CcSEcCtD
Ifosfamide—Body temperature increased—Methotrexate—hematologic cancer	2.34e-06	2.7e-05	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.34e-06	2.69e-05	CcSEcCtD
Ifosfamide—Paraesthesia—Doxorubicin—hematologic cancer	2.3e-06	2.66e-05	CcSEcCtD
Ifosfamide—Dyspnoea—Doxorubicin—hematologic cancer	2.29e-06	2.64e-05	CcSEcCtD
Ifosfamide—Feeling abnormal—Epirubicin—hematologic cancer	2.29e-06	2.63e-05	CcSEcCtD
Ifosfamide—Somnolence—Doxorubicin—hematologic cancer	2.28e-06	2.63e-05	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Epirubicin—hematologic cancer	2.27e-06	2.61e-05	CcSEcCtD
Ifosfamide—Vomiting—Prednisone—hematologic cancer	2.25e-06	2.6e-05	CcSEcCtD
Ifosfamide—Rash—Prednisone—hematologic cancer	2.24e-06	2.58e-05	CcSEcCtD
Ifosfamide—Dermatitis—Prednisone—hematologic cancer	2.23e-06	2.57e-05	CcSEcCtD
Ifosfamide—Decreased appetite—Doxorubicin—hematologic cancer	2.23e-06	2.57e-05	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.22e-06	2.55e-05	CcSEcCtD
Ifosfamide—Fatigue—Doxorubicin—hematologic cancer	2.21e-06	2.55e-05	CcSEcCtD
Ifosfamide—Urticaria—Epirubicin—hematologic cancer	2.2e-06	2.54e-05	CcSEcCtD
Ifosfamide—Pain—Doxorubicin—hematologic cancer	2.19e-06	2.53e-05	CcSEcCtD
Ifosfamide—Constipation—Doxorubicin—hematologic cancer	2.19e-06	2.53e-05	CcSEcCtD
Ifosfamide—Body temperature increased—Epirubicin—hematologic cancer	2.19e-06	2.53e-05	CcSEcCtD
Ifosfamide—Abdominal pain—Epirubicin—hematologic cancer	2.19e-06	2.53e-05	CcSEcCtD
Ifosfamide—Hypersensitivity—Methotrexate—hematologic cancer	2.18e-06	2.52e-05	CcSEcCtD
Ifosfamide—Asthenia—Methotrexate—hematologic cancer	2.13e-06	2.45e-05	CcSEcCtD
Ifosfamide—Feeling abnormal—Doxorubicin—hematologic cancer	2.11e-06	2.44e-05	CcSEcCtD
Ifosfamide—Nausea—Prednisone—hematologic cancer	2.11e-06	2.43e-05	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.1e-06	2.42e-05	CcSEcCtD
Ifosfamide—Pruritus—Methotrexate—hematologic cancer	2.1e-06	2.42e-05	CcSEcCtD
Ifosfamide—Hypersensitivity—Epirubicin—hematologic cancer	2.04e-06	2.35e-05	CcSEcCtD
Ifosfamide—Urticaria—Doxorubicin—hematologic cancer	2.04e-06	2.35e-05	CcSEcCtD
Ifosfamide—Abdominal pain—Doxorubicin—hematologic cancer	2.03e-06	2.34e-05	CcSEcCtD
Ifosfamide—Body temperature increased—Doxorubicin—hematologic cancer	2.03e-06	2.34e-05	CcSEcCtD
Ifosfamide—Diarrhoea—Methotrexate—hematologic cancer	2.03e-06	2.34e-05	CcSEcCtD
Ifosfamide—Asthenia—Epirubicin—hematologic cancer	1.99e-06	2.29e-05	CcSEcCtD
Ifosfamide—Pruritus—Epirubicin—hematologic cancer	1.96e-06	2.26e-05	CcSEcCtD
Ifosfamide—Dizziness—Methotrexate—hematologic cancer	1.96e-06	2.26e-05	CcSEcCtD
Ifosfamide—Diarrhoea—Epirubicin—hematologic cancer	1.9e-06	2.19e-05	CcSEcCtD
Ifosfamide—Hypersensitivity—Doxorubicin—hematologic cancer	1.89e-06	2.18e-05	CcSEcCtD
Ifosfamide—Vomiting—Methotrexate—hematologic cancer	1.88e-06	2.17e-05	CcSEcCtD
Ifosfamide—Rash—Methotrexate—hematologic cancer	1.87e-06	2.15e-05	CcSEcCtD
Ifosfamide—Dermatitis—Methotrexate—hematologic cancer	1.87e-06	2.15e-05	CcSEcCtD
Ifosfamide—Asthenia—Doxorubicin—hematologic cancer	1.84e-06	2.12e-05	CcSEcCtD
Ifosfamide—Dizziness—Epirubicin—hematologic cancer	1.83e-06	2.11e-05	CcSEcCtD
Ifosfamide—Pruritus—Doxorubicin—hematologic cancer	1.82e-06	2.09e-05	CcSEcCtD
Ifosfamide—Vomiting—Epirubicin—hematologic cancer	1.76e-06	2.03e-05	CcSEcCtD
Ifosfamide—Nausea—Methotrexate—hematologic cancer	1.76e-06	2.03e-05	CcSEcCtD
Ifosfamide—Diarrhoea—Doxorubicin—hematologic cancer	1.76e-06	2.02e-05	CcSEcCtD
Ifosfamide—Rash—Epirubicin—hematologic cancer	1.75e-06	2.01e-05	CcSEcCtD
Ifosfamide—Dermatitis—Epirubicin—hematologic cancer	1.75e-06	2.01e-05	CcSEcCtD
Ifosfamide—Dizziness—Doxorubicin—hematologic cancer	1.7e-06	1.96e-05	CcSEcCtD
Ifosfamide—Nausea—Epirubicin—hematologic cancer	1.65e-06	1.9e-05	CcSEcCtD
Ifosfamide—Vomiting—Doxorubicin—hematologic cancer	1.63e-06	1.88e-05	CcSEcCtD
Ifosfamide—Rash—Doxorubicin—hematologic cancer	1.62e-06	1.86e-05	CcSEcCtD
Ifosfamide—Dermatitis—Doxorubicin—hematologic cancer	1.62e-06	1.86e-05	CcSEcCtD
Ifosfamide—Nausea—Doxorubicin—hematologic cancer	1.52e-06	1.76e-05	CcSEcCtD
Ifosfamide—CYP2C9—Metabolism—ABCC3—hematologic cancer	1.33e-06	0.000183	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—TXN—hematologic cancer	1.33e-06	0.000183	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTO1—hematologic cancer	1.33e-06	0.000183	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—ABCB1—hematologic cancer	1.33e-06	0.000183	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.32e-06	0.000181	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ENO2—hematologic cancer	1.31e-06	0.00018	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—SPHK1—hematologic cancer	1.31e-06	0.000179	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ALOX5—hematologic cancer	1.3e-06	0.000179	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—GSTM1—hematologic cancer	1.29e-06	0.000178	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—NCOR1—hematologic cancer	1.29e-06	0.000178	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—ABCB1—hematologic cancer	1.29e-06	0.000177	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GSTP1—hematologic cancer	1.29e-06	0.000177	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GSTT1—hematologic cancer	1.27e-06	0.000175	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PIK3CD—hematologic cancer	1.27e-06	0.000174	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—NUP98—hematologic cancer	1.26e-06	0.000173	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—UGT1A1—hematologic cancer	1.25e-06	0.000172	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—GSTM1—hematologic cancer	1.25e-06	0.000172	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—ALB—hematologic cancer	1.25e-06	0.000172	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—NCOR1—hematologic cancer	1.25e-06	0.000172	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.25e-06	0.000172	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—MTAP—hematologic cancer	1.25e-06	0.000172	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CD44—hematologic cancer	1.25e-06	0.000171	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—NQO1—hematologic cancer	1.25e-06	0.000171	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—SDC1—hematologic cancer	1.24e-06	0.000171	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ADCY7—hematologic cancer	1.23e-06	0.000168	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—NCOA3—hematologic cancer	1.23e-06	0.000168	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—ABCB1—hematologic cancer	1.22e-06	0.000168	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—SLC22A1—hematologic cancer	1.22e-06	0.000168	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CRABP1—hematologic cancer	1.22e-06	0.000168	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CD44—hematologic cancer	1.22e-06	0.000168	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—NQO1—hematologic cancer	1.22e-06	0.000168	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—NUP214—hematologic cancer	1.22e-06	0.000167	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.21e-06	0.000166	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PIK3R1—hematologic cancer	1.2e-06	0.000165	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—MTR—hematologic cancer	1.19e-06	0.000164	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ABCG2—hematologic cancer	1.19e-06	0.000164	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ALOX5—hematologic cancer	1.19e-06	0.000163	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.19e-06	0.000163	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—NCOR1—hematologic cancer	1.19e-06	0.000163	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GSTM1—hematologic cancer	1.19e-06	0.000163	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CYCS—hematologic cancer	1.18e-06	0.000162	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—HSP90AA1—hematologic cancer	1.17e-06	0.000161	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.17e-06	0.000161	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ENO2—hematologic cancer	1.17e-06	0.000161	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CYCS—hematologic cancer	1.15e-06	0.000159	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—NUP98—hematologic cancer	1.15e-06	0.000158	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	1.15e-06	0.000157	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—MTHFR—hematologic cancer	1.14e-06	0.000157	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTT1—hematologic cancer	1.13e-06	0.000156	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.12e-06	0.000154	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ADCY7—hematologic cancer	1.12e-06	0.000154	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—NCOA3—hematologic cancer	1.12e-06	0.000154	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.12e-06	0.000153	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—FHL2—hematologic cancer	1.11e-06	0.000153	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—NUP214—hematologic cancer	1.11e-06	0.000152	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—SDC1—hematologic cancer	1.11e-06	0.000152	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—MTHFR—hematologic cancer	1.11e-06	0.000152	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PIK3CB—hematologic cancer	1.11e-06	0.000152	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.1e-06	0.000151	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—AGRN—hematologic cancer	1.09e-06	0.00015	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—MTR—hematologic cancer	1.09e-06	0.000149	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ABCG2—hematologic cancer	1.09e-06	0.000149	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ENO2—hematologic cancer	1.07e-06	0.000147	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.06e-06	0.000145	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CD44—hematologic cancer	1.06e-06	0.000145	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—NQO1—hematologic cancer	1.06e-06	0.000145	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—MTHFR—hematologic cancer	1.05e-06	0.000144	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.05e-06	0.000144	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GSTP1—hematologic cancer	1.04e-06	0.000143	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—HMMR—hematologic cancer	1.03e-06	0.000142	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—IDH2—hematologic cancer	1.03e-06	0.000142	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTT1—hematologic cancer	1.03e-06	0.000142	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.03e-06	0.000142	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.02e-06	0.00014	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GSTP1—hematologic cancer	1.02e-06	0.00014	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—SDC1—hematologic cancer	1.01e-06	0.000139	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1e-06	0.000137	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYCS—hematologic cancer	1e-06	0.000137	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	9.93e-07	0.000136	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—ABCB1—hematologic cancer	9.85e-07	0.000135	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.76e-07	0.000134	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ARNTL—hematologic cancer	9.73e-07	0.000134	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	9.66e-07	0.000133	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ABCB1—hematologic cancer	9.63e-07	0.000132	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CG—hematologic cancer	9.6e-07	0.000132	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GSTM1—hematologic cancer	9.56e-07	0.000131	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—NCOR1—hematologic cancer	9.56e-07	0.000131	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PTEN—hematologic cancer	9.56e-07	0.000131	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	9.54e-07	0.000131	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CA9—hematologic cancer	9.47e-07	0.00013	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ACP5—hematologic cancer	9.47e-07	0.00013	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CD44—hematologic cancer	9.43e-07	0.00013	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—NQO1—hematologic cancer	9.43e-07	0.00013	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—NCOR1—hematologic cancer	9.35e-07	0.000128	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GSTM1—hematologic cancer	9.35e-07	0.000128	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NCOR2—hematologic cancer	9.34e-07	0.000128	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CG—hematologic cancer	9.31e-07	0.000128	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	9.23e-07	0.000127	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—EP300—hematologic cancer	9.12e-07	0.000125	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	9.12e-07	0.000125	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	8.94e-07	0.000123	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYCS—hematologic cancer	8.92e-07	0.000123	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CREBBP—hematologic cancer	8.9e-07	0.000122	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—IDH1—hematologic cancer	8.9e-07	0.000122	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	8.87e-07	0.000122	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GSTP1—hematologic cancer	8.81e-07	0.000121	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CG—hematologic cancer	8.8e-07	0.000121	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTO1—hematologic cancer	8.8e-07	0.000121	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—TXN—hematologic cancer	8.8e-07	0.000121	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ABCC3—hematologic cancer	8.8e-07	0.000121	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CREBBP—hematologic cancer	8.63e-07	0.000119	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SPHK1—hematologic cancer	8.61e-07	0.000118	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CD44—hematologic cancer	8.6e-07	0.000118	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—NQO1—hematologic cancer	8.6e-07	0.000118	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	8.53e-07	0.000117	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—MTHFR—hematologic cancer	8.45e-07	0.000116	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CD—hematologic cancer	8.44e-07	0.000116	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	8.42e-07	0.000116	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ABCB1—hematologic cancer	8.34e-07	0.000115	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—ALB—hematologic cancer	8.33e-07	0.000114	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—UGT1A1—hematologic cancer	8.27e-07	0.000114	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—MTHFR—hematologic cancer	8.26e-07	0.000113	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CD—hematologic cancer	8.18e-07	0.000112	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CREBBP—hematologic cancer	8.16e-07	0.000112	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYCS—hematologic cancer	8.14e-07	0.000112	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GSTM1—hematologic cancer	8.1e-07	0.000111	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—NCOR1—hematologic cancer	8.1e-07	0.000111	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	8.08e-07	0.000111	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—ALB—hematologic cancer	8.08e-07	0.000111	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SLC22A1—hematologic cancer	8.05e-07	0.000111	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CRABP1—hematologic cancer	8.05e-07	0.000111	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.98e-07	0.00011	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3R1—hematologic cancer	7.97e-07	0.000109	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTP1—hematologic cancer	7.87e-07	0.000108	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ALOX5—hematologic cancer	7.84e-07	0.000108	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CD—hematologic cancer	7.74e-07	0.000106	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3R1—hematologic cancer	7.73e-07	0.000106	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—ALB—hematologic cancer	7.64e-07	0.000105	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	7.61e-07	0.000105	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NUP98—hematologic cancer	7.6e-07	0.000104	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ABCB1—hematologic cancer	7.45e-07	0.000102	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ADCY7—hematologic cancer	7.37e-07	0.000101	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NCOA3—hematologic cancer	7.37e-07	0.000101	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CB—hematologic cancer	7.36e-07	0.000101	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NUP214—hematologic cancer	7.32e-07	0.000101	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3R1—hematologic cancer	7.31e-07	0.0001	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.28e-07	9.99e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—NCOR1—hematologic cancer	7.23e-07	9.93e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTM1—hematologic cancer	7.23e-07	9.93e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ABCG2—hematologic cancer	7.17e-07	9.85e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—MTR—hematologic cancer	7.17e-07	9.85e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTP1—hematologic cancer	7.17e-07	9.85e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—MTHFR—hematologic cancer	7.16e-07	9.83e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CB—hematologic cancer	7.13e-07	9.8e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CG—hematologic cancer	7.1e-07	9.75e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ENO2—hematologic cancer	7.04e-07	9.66e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CG—hematologic cancer	6.94e-07	9.53e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.94e-07	9.53e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTT1—hematologic cancer	6.82e-07	9.37e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ABCB1—hematologic cancer	6.79e-07	9.32e-05	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PIK3CA—hematologic cancer	6.75e-07	9.27e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CB—hematologic cancer	6.74e-07	9.26e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SDC1—hematologic cancer	6.67e-07	9.16e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—NCOR1—hematologic cancer	6.59e-07	9.05e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTM1—hematologic cancer	6.59e-07	9.05e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CREBBP—hematologic cancer	6.58e-07	9.04e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CREBBP—hematologic cancer	6.44e-07	8.84e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—MTHFR—hematologic cancer	6.39e-07	8.77e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PTEN—hematologic cancer	6.36e-07	8.73e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.31e-07	8.66e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CD—hematologic cancer	6.24e-07	8.57e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—ALB—hematologic cancer	6.16e-07	8.46e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PTEN—hematologic cancer	6.16e-07	8.46e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CD—hematologic cancer	6.1e-07	8.38e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—EP300—hematologic cancer	6.06e-07	8.33e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ALB—hematologic cancer	6.02e-07	8.27e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CG—hematologic cancer	6.01e-07	8.26e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3R1—hematologic cancer	5.9e-07	8.1e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—EP300—hematologic cancer	5.88e-07	8.07e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PTEN—hematologic cancer	5.83e-07	8e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—MTHFR—hematologic cancer	5.82e-07	8e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3R1—hematologic cancer	5.76e-07	7.91e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CD44—hematologic cancer	5.67e-07	7.79e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NQO1—hematologic cancer	5.67e-07	7.79e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.63e-07	7.73e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CREBBP—hematologic cancer	5.57e-07	7.66e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—EP300—hematologic cancer	5.56e-07	7.63e-05	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—AKT1—hematologic cancer	5.51e-07	7.57e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CB—hematologic cancer	5.44e-07	7.47e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CG—hematologic cancer	5.37e-07	7.37e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYCS—hematologic cancer	5.37e-07	7.37e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	5.33e-07	7.32e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CB—hematologic cancer	5.32e-07	7.31e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CD—hematologic cancer	5.29e-07	7.26e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ALB—hematologic cancer	5.22e-07	7.17e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.13e-07	7.05e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3R1—hematologic cancer	4.99e-07	6.85e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CREBBP—hematologic cancer	4.98e-07	6.83e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CG—hematologic cancer	4.89e-07	6.72e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTP1—hematologic cancer	4.73e-07	6.5e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CD—hematologic cancer	4.72e-07	6.48e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PTEN—hematologic cancer	4.7e-07	6.46e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ALB—hematologic cancer	4.66e-07	6.4e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CB—hematologic cancer	4.61e-07	6.33e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PTEN—hematologic cancer	4.6e-07	6.31e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CREBBP—hematologic cancer	4.54e-07	6.23e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CA—hematologic cancer	4.49e-07	6.16e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—EP300—hematologic cancer	4.48e-07	6.16e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ABCB1—hematologic cancer	4.48e-07	6.15e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3R1—hematologic cancer	4.46e-07	6.12e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—EP300—hematologic cancer	4.38e-07	6.02e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CA—hematologic cancer	4.35e-07	5.97e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NCOR1—hematologic cancer	4.35e-07	5.97e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTM1—hematologic cancer	4.35e-07	5.97e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CD—hematologic cancer	4.3e-07	5.91e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ALB—hematologic cancer	4.25e-07	5.83e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CB—hematologic cancer	4.11e-07	5.65e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CA—hematologic cancer	4.11e-07	5.65e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3R1—hematologic cancer	4.06e-07	5.58e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PTEN—hematologic cancer	3.98e-07	5.47e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.84e-07	5.28e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—EP300—hematologic cancer	3.8e-07	5.21e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CB—hematologic cancer	3.75e-07	5.15e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—AKT1—hematologic cancer	3.66e-07	5.03e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PTEN—hematologic cancer	3.55e-07	4.88e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—AKT1—hematologic cancer	3.55e-07	4.88e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—EP300—hematologic cancer	3.39e-07	4.65e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—AKT1—hematologic cancer	3.36e-07	4.61e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CA—hematologic cancer	3.32e-07	4.56e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CA—hematologic cancer	3.24e-07	4.45e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PTEN—hematologic cancer	3.24e-07	4.45e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CG—hematologic cancer	3.23e-07	4.43e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—EP300—hematologic cancer	3.09e-07	4.24e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.99e-07	4.11e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.84e-07	3.9e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CA—hematologic cancer	2.81e-07	3.86e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ALB—hematologic cancer	2.8e-07	3.85e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—AKT1—hematologic cancer	2.71e-07	3.72e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.68e-07	3.68e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—AKT1—hematologic cancer	2.65e-07	3.64e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CA—hematologic cancer	2.51e-07	3.44e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.47e-07	3.4e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—AKT1—hematologic cancer	2.29e-07	3.15e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CA—hematologic cancer	2.29e-07	3.14e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PTEN—hematologic cancer	2.14e-07	2.93e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—AKT1—hematologic cancer	2.05e-07	2.81e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—EP300—hematologic cancer	2.04e-07	2.8e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—AKT1—hematologic cancer	1.87e-07	2.56e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.51e-07	2.07e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—AKT1—hematologic cancer	1.23e-07	1.69e-05	CbGpPWpGaD
